---
title: "Apogee names Christopher Ede president of Architectural Glass segment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291788818.md"
description: "Apogee Enterprises Inc. has appointed Christopher W. Ede as president of its Architectural Glass segment. Ede previously served as vice president of business development since joining the company in 2022 and brings over 20 years of experience in strategy, global P&L management, M&A, finance, and portfolio transformation."
datetime: "2026-07-06T10:31:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291788818.md)
  - [en](https://longbridge.com/en/news/291788818.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291788818.md)
generator: "portal-rs"
---

# Apogee names Christopher Ede president of Architectural Glass segment

-   Apogee named Christopher W. Ede president of its Architectural Glass segment. \* Ede previously served as vice president of business development since joining the company in 2022. \* He has more than 20 years’ experience spanning strategy, global P&L management, M&A, finance, and portfolio transformation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Enterprises Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607060630BIZWIRE\_USPR\_\_\_\_\_20260706\_BW085467) on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [APOG.US](https://longbridge.com/en/quote/APOG.US.md)

## Related News & Research

- [Apogee Enterprises to acquire GroGlass for up to €62.5M](https://longbridge.com/en/news/297827400.md)
- [Apogee Therapeutics shares face Nasdaq suspension as company moves to delist after AbbVie merger](https://longbridge.com/en/news/297917721.md)
- [Agenus releases corporate overview presentation on botensilimab-balstilimab neoadjuvant colon cancer data](https://longbridge.com/en/news/297820304.md)
- [Lululemon's Comparable Sales Fell 9%. Can New CEO Heidi O'Neill Turn Things Around or Is the Brand Broken?](https://longbridge.com/en/news/298017136.md)
- [REMAX Names Industry Veteran Alex Vidal as President | REAX Stock News](https://longbridge.com/en/news/297697013.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**